Baker McKenzie advised Embracer Group on the deal. Embracer Group completed the application for admission to trading of the company’s class B shares on Nasdaq Stockholm. Embracer...
Embracer Group’s Class B Shares Offering
Biovica International’s Preferential Rights Offering
Baker McKenzie advised Biovica on the deal. Biovica International AB (publ), listed on Nasdaq First North Premier Growth Market, executed a fully guaranteed preferential rights issue of...
Catena’s Shares Offering
Baker McKenzie acted as legal advisor to the banks on the deal. Catena AB (publ) executed a primary issuance of shares of approximately SEK 1.6 billion...
Sampo’s Dual Listing on Nasdaq Stockholm
Baker McKenzie advised SEB on the deal. Hannes Snellman acted as legal counsel to Sampo plc. Sampo plc has completed a dual listing on Nasdaq Stockholm. ...
Sdiptech’s Shares Offering
Baker McKenzie advised Sdiptech on the deal. Sdiptech AB executed a primary issuance of shares of approximately SEK 506 million (approx. $47.5 million) where the subscription price...
Re:NewCell’s Shares Offering
Baker McKenzie advised Nordea and Pareto on the deal. Vinge has advised Re:NewCell. Re:NewCell AB (publ) has carried out a primary issuance of shares of approximately...
Accelleron’s Spin-off from ABB
Baker McKenzie advised Skandinaviska Enskilda Banken in the deal. Accelleron executed a spin-off from ABB. Skandinaviska Enskilda Banken acted as Issuer Agent of Swedish Depositary Receipts. Accelleron...
Azelio’s Preferential Rights Offering
Baker McKenzie advised Carnegie and Pareto Securities on the offering. Vinge has advised Azelio. Azelio AB executed a a fully guaranteed preferential rights issuance of approximately SEK...
Cinis Fertilizer’s Initial Public Offering
Baker McKenzie advised the Joint Bookrunners on the offering. Cinis Fertilizer AB’s shares started trading on Nasdaq First North Premier Growth Market. The price in the...
Xbrane Biopharma’s Shares Offering
Baker McKenzie advised Xbrane Biopharma on the deal. Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price...
Boule Diagnostics AB’s SEK 150 Million Preferential Rights Issue
Cirio advised Boule Diagnostics AB on the deal, while Baker McKenzie acted as legal advisor to Pareto Securities. Boule Diagnostics AB (publ) announced its fully secured preferential...
BioInvent’s Shares Offering
Baker McKenzie acted as legal advisor to Kempen & Co and Pareto Securities on the deal. BioInvent International has carried out a primary issuance of shares...